Contrary to analyses including the temporal meta‐ROI, CSF p‐tau217 was no longer independently associated with age and APOE ɛ4 carriership, and the stronger associations between tau PET and cognitive decline in the symptomatic stage were no longer found. This evidence concerns the gene MAPT and Mental deterioration.